MEDINOL LTD.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 1992-12-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.medinol.com
NIRTRAKS Post-Market Study (NIRTRAKS)
Not Applicable
Completed
- Conditions
- de Novo Stenotic Lesions in Native Coronary Arteries
- Interventions
- Device: Stenting procedure
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Medinol Ltd.
- Target Recruit Count
- 65
- Registration Number
- NCT02455804
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
Not Applicable
Completed
- Conditions
- Coronary Artery Stenosis
- Interventions
- Device: ResoluteDevice: BioNIR
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- Medinol Ltd.
- Target Recruit Count
- 1919
- Registration Number
- NCT01995487
- Locations
- 🇺🇸
Piedmont Healthcare, Atlanta, Georgia, United States
🇪🇸Hospital Meixoeiro, Pontevedra, Vigo, Spain
🇮🇱Hadassah Hebrew University Medical Center, Jerusalem, Israel
Angiography Study of BioNIR Drug Eluting Stent System (NIREUS)
Phase 2
Completed
- Conditions
- Coronary Artery Stenosis
- Interventions
- Device: ResoluteDevice: BioNIR
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Medinol Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT01995500
- Locations
- 🇮🇱
Hadassah Hebrew University Medical Center, Jerusalem, Israel
X-MAS Biliary Study With Covered Biliary Stent
Not Applicable
Completed
- Conditions
- Biliary Tract Cancer
- Interventions
- Device: X-Suit NIR Covered Biliary Stent
- First Posted Date
- 2013-07-16
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Medinol Ltd.
- Target Recruit Count
- 68
- Registration Number
- NCT01899976
- Locations
- 🇳🇱
University Medical Center Utrecht, Utrecht, Heidelberglaan, Netherlands
🇮🇱Shaare Zedek Medical Center, Jerusalem, Israel
🇧🇪Hôpital Erasme Brussels (ULB), Brussels, Belgium
PIONIR Study (Presillionâ„¢ and Presillionâ„¢ Plus Stent Systems)
Phase 4
Completed
- Conditions
- Ischemic Heart Disease
- Interventions
- Device: Catheterization, stent deployment
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Medinol Ltd.
- Target Recruit Count
- 278
- Registration Number
- NCT00840775
- Locations
- 🇸🇪
Sahlgrenska University Hospital, Gothenburg, Sweden
🇩🇪Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Villingen-Schwenningen, Germany
🇮🇱Assaf Harofeh Medical Center, Zerifin, Israel
© Copyright 2025. All Rights Reserved by MedPath